199 related articles for article (PubMed ID: 25025847)
21. Expression of EphA2 protein is positively associated with age, tumor size and Fuhrman nuclear grade in clear cell renal cell carcinomas.
Wang L; Hu H; Tian F; Zhou W; Zhou S; Wang J
Int J Clin Exp Pathol; 2015; 8(10):13374-80. PubMed ID: 26722543
[TBL] [Abstract][Full Text] [Related]
22. Prognostic Significance of High EphA1-4 Expression Levels in Locally Advanced Gastric Cancer.
Inokuchi M; Nakagawa M; Baogok N; Takagi Y; Tanioka T; Gokita K; Okuno K; Kojima K
Anticancer Res; 2018 Mar; 38(3):1685-1693. PubMed ID: 29491103
[TBL] [Abstract][Full Text] [Related]
23. EphA2 overexpression correlates with poor prognosis in esophageal squamous cell carcinoma.
Miyazaki T; Kato H; Fukuchi M; Nakajima M; Kuwano H
Int J Cancer; 2003 Feb; 103(5):657-63. PubMed ID: 12494475
[TBL] [Abstract][Full Text] [Related]
24. Enhanced YB1/EphA2 axis signaling promotes acquired resistance to sunitinib and metastatic potential in renal cell carcinoma.
Ruan H; Li S; Bao L; Zhang X
Oncogene; 2020 Sep; 39(38):6113-6128. PubMed ID: 32814829
[TBL] [Abstract][Full Text] [Related]
25. Erythropoietin-Producing Hepatocellular A1 is an Independent Prognostic Factor for Gastric Cancer.
Nakagawa M; Inokuchi M; Takagi Y; Kato K; Sugita H; Otsuki S; Kojima K; Uetake H; Sugihara K
Ann Surg Oncol; 2015 Jul; 22(7):2329-35. PubMed ID: 25391265
[TBL] [Abstract][Full Text] [Related]
26. miR-141 is a key regulator of renal cell carcinoma proliferation and metastasis by controlling EphA2 expression.
Chen X; Wang X; Ruan A; Han W; Zhao Y; Lu X; Xiao P; Shi H; Wang R; Chen L; Chen S; Du Q; Yang H; Zhang X
Clin Cancer Res; 2014 May; 20(10):2617-30. PubMed ID: 24647573
[TBL] [Abstract][Full Text] [Related]
27. Expression of EphA2 is prognostic of disease-free interval and overall survival in surgically treated patients with renal cell carcinoma.
Herrem CJ; Tatsumi T; Olson KS; Shirai K; Finke JH; Bukowski RM; Zhou M; Richmond AL; Derweesh I; Kinch MS; Storkus WJ
Clin Cancer Res; 2005 Jan; 11(1):226-31. PubMed ID: 15671550
[TBL] [Abstract][Full Text] [Related]
28. Activation of EphA1-Epha receptor axis attenuates diabetic nephropathy in mice.
Li Y; Yan H; Wang F; Huang S; Zhang Y; Wang Z; Zhong M; Zhang W
Biochem Biophys Res Commun; 2017 May; 486(3):693-699. PubMed ID: 28341121
[TBL] [Abstract][Full Text] [Related]
29. Mapping the Universe of Eph Receptor and Ephrin Ligand Transcripts in Epithelial and Fiber Cells of the Eye Lens.
Vu MP; Cheng C
Cells; 2022 Oct; 11(20):. PubMed ID: 36291158
[TBL] [Abstract][Full Text] [Related]
30. Expression of EphA2 and Ephrin A-1 in carcinoma of the urinary bladder.
Abraham S; Knapp DW; Cheng L; Snyder PW; Mittal SK; Bangari DS; Kinch M; Wu L; Dhariwal J; Mohammed SI
Clin Cancer Res; 2006 Jan; 12(2):353-60. PubMed ID: 16428472
[TBL] [Abstract][Full Text] [Related]
31. Differential gene expression of Eph-ephrin A1 and LEPR-LEP with high or low number of embryos in pigs during implantation.
Fu Y; Knox RV; Li L; Ren S
Reprod Domest Anim; 2018 Aug; 53(4):937-946. PubMed ID: 29740882
[TBL] [Abstract][Full Text] [Related]
32. [Expression and prognostic significance of EphA2 and EphrinA-1 in ovarian serous carcinomas].
Han LP; Liu JF; Liu XR; Dong ZM; Suo ZH
Sichuan Da Xue Xue Bao Yi Xue Ban; 2011 Mar; 42(2):179-84. PubMed ID: 21500549
[TBL] [Abstract][Full Text] [Related]
33. Increased expression of EphA1 protein in prostate cancers correlates with high Gleason score.
Peng L; Wang H; Dong Y; Ma J; Wen J; Wu J; Wang X; Zhou X; Wang J
Int J Clin Exp Pathol; 2013; 6(9):1854-60. PubMed ID: 24040450
[TBL] [Abstract][Full Text] [Related]
34. Eph/ephrin profiling in human breast cancer reveals significant associations between expression level and clinical outcome.
Brantley-Sieders DM; Jiang A; Sarma K; Badu-Nkansah A; Walter DL; Shyr Y; Chen J
PLoS One; 2011; 6(9):e24426. PubMed ID: 21935409
[TBL] [Abstract][Full Text] [Related]
35. Alteration of the EphA2/Ephrin-A signaling axis in psoriatic epidermis.
Gordon K; Kochkodan JJ; Blatt H; Lin SY; Kaplan N; Johnston A; Swindell WR; Hoover P; Schlosser BJ; Elder JT; Gudjonsson JE; Getsios S
J Invest Dermatol; 2013 Mar; 133(3):712-722. PubMed ID: 23190894
[TBL] [Abstract][Full Text] [Related]
36. Biological and structural characterization of glycosylation on ephrin-A1, a preferred ligand for EphA2 receptor tyrosine kinase.
Ferluga S; Hantgan R; Goldgur Y; Himanen JP; Nikolov DB; Debinski W
J Biol Chem; 2013 Jun; 288(25):18448-57. PubMed ID: 23661698
[TBL] [Abstract][Full Text] [Related]
37. Correlation of EPHA2 overexpression with high microvessel count in human primary colorectal cancer.
Kataoka H; Igarashi H; Kanamori M; Ihara M; Wang JD; Wang YJ; Li ZY; Shimamura T; Kobayashi T; Maruyama K; Nakamura T; Arai H; Kajimura M; Hanai H; Tanaka M; Sugimura H
Cancer Sci; 2004 Feb; 95(2):136-41. PubMed ID: 14965363
[TBL] [Abstract][Full Text] [Related]
38. The G-protein-coupled receptor CLR is upregulated in an autocrine loop with adrenomedullin in clear cell renal cell carcinoma and associated with poor prognosis.
Nikitenko LL; Leek R; Henderson S; Pillay N; Turley H; Generali D; Gunningham S; Morrin HR; Pellagatti A; Rees MC; Harris AL; Fox SB
Clin Cancer Res; 2013 Oct; 19(20):5740-8. PubMed ID: 23969937
[TBL] [Abstract][Full Text] [Related]
39. Low level of PDZ domain containing 1 (PDZK1) predicts poor clinical outcome in patients with clear cell renal cell carcinoma.
Zheng J; Wang L; Peng Z; Yang Y; Feng D; He J
EBioMedicine; 2017 Feb; 15():62-72. PubMed ID: 27993630
[TBL] [Abstract][Full Text] [Related]
40. Expression of Eph receptors and their ligands, ephrins, during lipopolysaccharide fever in rats.
Ivanov AI; Steiner AA; Scheck AC; Romanovsky AA
Physiol Genomics; 2005 Apr; 21(2):152-60. PubMed ID: 15671251
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
